ICHNOS
LIVE

Serial Number

79290390

Owner

ICHNOS SCIENCES SA

Attorney

Jeffrey H. Greger

Filing Date

May 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ICHNOS Trademark

Serial Number: 79290390 • Registration: 6413608

ICHNOS is a trademark filed by ICHNOS SCIENCES SA on May 6, 2020. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

ICHNOS SCIENCES SA (9 trademarks)

CHEMIN DE LA COMBETA 5 10166 , CH

Entity Type: 33

Trademark Details

Filing Date

May 6, 2020

Registration Date

July 13, 2021

Published for Opposition

April 27, 2021

Goods & Services

Educational services, namely, providing workshops and seminars in the fields of cancer treatment, oncology, immunology and pain management; publication of journals featuring research articles and clinical trials for pharmaceutical preparations; education services, namely, conducting online instruction and courses in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; training in the use and operation of medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions, and training programs in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; educational services, namely, providing non-downloadable webinars in the field of health and medical information and distribution of course material in connection therewith; education services, namely, developing, arranging and conducting educational programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; providing training programs and developing training programs in the nature of learning methodologies for others relating to the use and operation of medical devices, medical research apparatus and consultation relating thereto; providing online non-downloadable publications, namely, instructional materials in the nature of worksheets and textbooks, featuring study materials in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; conducting educational seminars in the fields of healthcare, the use of pharmaceuticals, and medical devices, medical research, surgery, medical science and medicine

Pharmaceutical preparations for human use for the treatment of respiratory disorders; nasal spray preparations; medical and pharmaceutical preparations, namely, inhaler preparations for treatment of Chronic Obstructive Pulmonary Disease (COPD); preparations containing opium alkaloids; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive cold preparations; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances used in the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation used in the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, and for the treatment of inflammatory disorders, and for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical and biological preparations for the treatment of cancer; dermatological pharmaceutical preparations; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, blood clotting aid and delivery systems for use in human and veterinary medicine; pharmaceutical preparations, namely, drug delivery systems comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; medicated skin care preparations; medicated skin care preparations, namely, gels; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations for preventing swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint diseases; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelminthics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; analgesic preparations; preparations for the treatment of asthma; preparations for therapeutic or medical purposes, namely, therapeutic medicated skin preparations for treatment of skin diseases; decongestant nasal sprays * ; pharmaceutical products for the treatment of erectile dysfunction; pharmaceuticals for the treatment of erectile dysfunction *

Soaps for cosmetic use, namely, cosmetic soaps; skin soaps; shampoos; sunscreens for cosmetic use; perfumery products, namely, perfumery, deodorants for personal use; essential oils; body powders; cosmetic products, namely, cosmetics; antiaging creams; hair lotions; cosmetic skin care preparations; skin creams; skin moisturizing gels; face washing creams, facial cleansers, washing products for facial treatment in the nature of non-medicated soaps; moisturizing body lotions; non-medicinal mouthwashes

Campaigns for patient support programs, namely, advertising services promoting public awareness of cancer patients, pain management, skin care, diabetes management, asthma management, chronic obstructive pulmonary disease (COPD) management and of respiratory disease management

Licensing of patents; licensing of trademarks; intellectual property licensing in the nature of licensing of intellectual property rights

Providing information in the field of medicine and health in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical services in the field of oncology, pain management; dermatology, diabetology, respiratory disease and dietetic advisory services; medical assistance in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; hygiene care for human beings in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical clinic services; dietetic advisory services; disseminating medical information to patients for better lifestyle management to handle the treatment of side effects in the course of treatment of cancer, pain management, skin care, management of diabetes, management of asthma, Chronic Obstructive Pulmonary Disease (COPD) and respiratory diseases

Medical apparatus and instruments, namely, spirometers; medical devices, namely, nasal sprayers in the nature of nasal irrigation vessels, inhalers and nebulizers sold empty; medical devices, namely, autoanalysers; chromatographic medical diagnostic apparatus for testing cancer cells

Scientific research for medical purposes in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis, testing in the field of oncology, immunology and pain management; medical research in the fields of oncology, immunology and pain management; clinical research in the fields of oncology, immunology and pain management; scientific research and development; pharmaceutical drug development services; research and development for new products for others; chemical, pharmaceutical, nutraceutical and nutritional analysis and research; dermo-cosmetic and biotechnological analysis and research; design and testing for new product development; diagnostic product testing and analysis, namely, medical research and new product research for industrial use; scientific research in the fields of chemistry, biotechnology and pharmacology; medical and pharmaceutical research services, scientific research services for medical purposes in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars, bacteriological research services, biomedical research services, laboratory research services in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars, clinical trial services in the nature of conducting clinical trials for others, pharmacological research services, medical research laboratory services in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars, and scientific and technological services and research and design relating thereto, namely, scientific research, analysis, testing in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars * ; pharmaceutical research and development *

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Dec 7, 2022 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 15, 2022 INPR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Mar 15, 2022 CORR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 15, 2022 APRE
CORRECTION UNDER SECTION 7 - PROCESSED
Mar 15, 2022 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 15, 2022 APRE
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Mar 7, 2022 LIMN
CORRECTION TRANSACTION RECEIVED FROM IB
Dec 25, 2021 CRCV
LIMITATION OF GOODS RECEIVED FROM IB
Dec 25, 2021 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 29, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 10, 2021 FICS
FINAL DISPOSITION PROCESSED
Nov 10, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 13, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 13, 2021 R.PR
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jun 10, 2021 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Jun 6, 2021 LIMG
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 27, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Apr 24, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 7, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 7, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 23, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 23, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 23, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 23, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 23, 2021 CNEA
ASSIGNED TO EXAMINER
Mar 23, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 5, 2021 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Nov 7, 2020 NREP
REFUSAL PROCESSED BY IB
Sep 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 7, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 3, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 4, 2020 RFCR
APPLICATION FILING RECEIPT MAILED
Aug 4, 2020 MAFR
NON-FINAL ACTION WRITTEN
Aug 3, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 31, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 30, 2020 REPR